Code Biotherapeutics, Inc. — Form D

Code Biotherapeutics, Inc. of HATFIELD, PA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-22. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Edward MathersDirectorSouth San Francisco, CA
Russ FeinDirectorLouisville, CO
Russ FeinExecutive OfficerLouisville, CO
Dmitry KuzminDirectorSt Peter Port, Y7
Joseph TruittDirectorHatfield, PA
Victor StoneDirectorHatfield, PA
Brian McVeighDirectorHatfield, PA
Brian McVeighExecutive OfficerHatfield, PA
Kathy RouanDirectorHatfield, PA
Robert C GettsExecutive OfficerHatfield, PA
Robert LinDirectorHatfield, PA
Lauren C KaskielExecutive OfficerHatfield, PA
Erin C BrubakerExecutive OfficerHatfield, PA
Dmitry C KuzminDirectorHatfield, PA
Victor C StoneDirectorHatfield, PA
Edward C MathersDirectorHatfield, PA
Robert C LinDirectorHatfield, PA

Other filings by this issuer (2)

FiledFormOfferingSold
2022-06-09D$75.0M$37.5M
2021-04-21D/A$10.0M$10.0M

More